Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
MAGEA3 is a member of the MAGEA gene family. Additionally we are shipping MAGEA3 Proteins (11) and and many more products for this protein.
Showing 10 out of 76 products:
Human Polyclonal MAGEA3 Primary Antibody for FACS, IHC (p) - ABIN390107
Guo, Wen, Huang, Paul, Wünsch, Itakura, Cochran: Detection of multiple melanoma-associated markers in melanoma cell lines by RT in situ PCR. in Experimental and molecular pathology 2003
Show all 7 references for ABIN390107
Human Polyclonal MAGEA3 Primary Antibody for IHC, WB - ABIN2782498
Connerotte, Van Pel, Godelaine, Tartour, Schuler-Thurner, Lucas, Thielemans, Schuler, Coulie: Functions of Anti-MAGE T-cells induced in melanoma patients under different vaccination modalities. in Cancer research 2008
Human Monoclonal MAGEA3 Primary Antibody for ELISA, WB - ABIN561731
Akiyama, Oshita, Kume, Iizuka, Miyata, Komiyama, Ashizawa, Yagoto, Abe, Mitsuya, Watanabe, Sugino, Yamaguchi, Nakasu: ?-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial. in BMC cancer 2013
Human Polyclonal MAGEA3 Primary Antibody for EIA, WB - ABIN358646
Dai, Yao: Nonuniformly-spaced photonic microwave delayline filter. in Optics express 2008
Progression free survival and levels of MAGE-A3 expression in non-small cell lung carcinoma patients with the three modes of acquired resistance are negatively correlated.
the crystal structures of MAGE-A3 and MAGE-A4 (show MAGEA4 Antibodies)
MAGEA3/6 positivity was associated with significantly better disease-free survival.
Anticancer effects of adenovirus-mediated calreticulin (show CALR Antibodies) and melanoma-associated antigen 3 expression on non-small cell lung cancer cells
our findings indicated that MAGE-A3 is a novel cancer stem cell antigen in bladder cancer
MAGE-A3 may serve as a potential prognostic marker for clear cell renal cell carcinoma (show MOK Antibodies)
Study describes a widespread mechanism to suppress AMPK (show PRKAA1 Antibodies) through its ubiquitination and degradation by the cancer-specific MAGE-A3/6-TRIM28 (show TRIM28 Antibodies) ubiquitin ligase. MAGE-A3 and MAGE-A6 (show MAGEA6 Antibodies) are highly similar proteins normally expressed only in the male germline but frequently re-activated in human cancers.
MAGE (show MAGEB10 Antibodies) proteins bind to KAP1 (show CDKN3 Antibodies), a gene repressor and ubiquitin E3 ligase which also binds KRAB domain containing zinc finger transcription factors (KZNFs), and MAGE (show MAGEB10 Antibodies) expression may affect KZNF mediated gene regulation.
Study demonstrated that the expression of MAGE-A3/4 antigen might be a valuable prognostic factor regarding survival in patients with NSCLC.
Data indicate that MAGE3, Survivin (show BIRC5 Antibodies) and B-cell maturation antigen (BCMA (show TNFRSF17 Antibodies)) mRNA-pulsed dendritic cells (DCs) are capable of stimulating tumor-associated antigens (TAA)-specific T-cell responses in multiple myeloma (MM) patients.
This gene is a member of the MAGEA gene family. The members of this family encode proteins with 50 to 80% sequence identity to each other. The promoters and first exons of the MAGEA genes show considerable variability, suggesting that the existence of this gene family enables the same function to be expressed under different transcriptional controls. The MAGEA genes are clustered at chromosomal location Xq28. They have been implicated in some hereditary disorders, such as dyskeratosis congenita.
melanoma antigen family A, 3
, MAGE-3 antigen
, antigen MZ2-D
, cancer/testis antigen 1.3
, cancer/testis antigen family 1, member 3
, melanoma-associated antigen 3